Missing or inadequate procedures for out-of-specification (OOS) results and failure investigations are among the most common deviations cited in FDA warning letters. This OOS and OOT investigations webinar reviews the regulatory requirements and how to meet them.
You'll follow the process from detecting an OOS result through the Phase I laboratory investigation and a Phase II full-scale investigation to concluding it, using a detailed flow chart that shows each step and its order.
The session explains the responsibilities of the analyst, supervisor and QA, how to structure an investigation report, how to handle out-of-trend (OOT) results and common pitfalls, with a review of OOS-related warning letter citations.
WHY SHOULD YOU ATTEND?
Most companies have OOS procedures, but they are often inadequate or not followed. This session guides you through the full process, from detecting an OOS result to informal and formal laboratory and batch investigations, so your procedures hold up.
It suits QA/QC and regulatory affairs directors, managers and specialists, and quality control laboratory staff.
AREA COVERED
- Regulatory requirements for OOS investigations
- Responsibilities of the analyst, supervisor and QA
- Phase I: the laboratory investigation
- Phase II: the full-scale investigation
- Concluding an investigation and structuring the report
- Out-of-trend investigations
- Common pitfalls during OOS investigations
- OOS-related citations in FDA warning letters
LEARNING OBJECTIVES
- Explain the regulatory requirements for investigating OOS results
- Define the roles of the analyst, supervisor and QA
- Conduct a Phase I laboratory investigation and a Phase II full-scale investigation
- Write an investigation report that documents the work properly
- Investigate out-of-trend results
- Avoid common pitfalls seen in warning letters
WHO WILL BENEFIT?
- Quality Assurance/Quality Control Directors, Managers, and Specialists
- Regulatory Affairs/Regulatory Compliance Directors, Managers, and Specialists
- Quality Control Laboratory Staff
Most companies have OOS procedures, but they are often inadequate or not followed. This session guides you through the full process, from detecting an OOS result to informal and formal laboratory and batch investigations, so your procedures hold up.
It suits QA/QC and regulatory affairs directors, managers and specialists, and quality control laboratory staff.
- Regulatory requirements for OOS investigations
- Responsibilities of the analyst, supervisor and QA
- Phase I: the laboratory investigation
- Phase II: the full-scale investigation
- Concluding an investigation and structuring the report
- Out-of-trend investigations
- Common pitfalls during OOS investigations
- OOS-related citations in FDA warning letters
- Explain the regulatory requirements for investigating OOS results
- Define the roles of the analyst, supervisor and QA
- Conduct a Phase I laboratory investigation and a Phase II full-scale investigation
- Write an investigation report that documents the work properly
- Investigate out-of-trend results
- Avoid common pitfalls seen in warning letters
- Quality Assurance/Quality Control Directors, Managers, and Specialists
- Regulatory Affairs/Regulatory Compliance Directors, Managers, and Specialists
- Quality Control Laboratory Staff
Speaker Profile
Danielle DeLucy
Danielle DeLucy, MS, is owner of ASA Training and Consulting, LLC which provides Pharmaceutical and Biologics based companies with training and quality systems assistance in order to meet Regulatory compliance. Prior to this role, Danielle has been in the industry for 15 years serving in numerous Quality Management Roles, such as the Director of Product Quality, the oversight of Sterility Assurance practices and provided QA oversight of numerous filling and packaging operations. Danielle began her QA career as a Quality Control Pharmaceutical Microbiologist at a contract laboratory where she performed various tests for their clients. In the years after, she …
Upcoming Webinars
Medical Device Cybersecurity Following FDA’s 2026 Premarket…
Managing Toxic Employees: Strategies For Leaders To Effecti…
California Meal and Rest Breaks: What You Don't Know Can Co…
Human Error Reduction Techniques for Floor Supervisors
Unlock Employee Loyalty: Stay Interviews Will Keep Them Eng…
Performance of Root Cause Analysis, CAPA, and Effectiveness…
Your AI Advantage: How HR Professionals Can Use Claude to S…
The Anti-Kickback Statute: Enforcement and Recent Updates
Empowering Conflict Resolution: Letting Go to Gain Control
Wage & Hour Laws: Ensuring Compliance with the Fair Labor S…
Using Copilot to Format Legal Documents in Microsoft Word
Dealing With Difficult People: At Work & In Life
Using Stay Interviews To Improve Employee Retention & Engag…
AI in Word - Smarter Writing and Document Creation with Cha…
FDA Current Trends in Compliance and Enforcement for FDA-Re…
Zero Acceptance Sampling to Reduce Inspection Costs
Why EBITDA Doesn't Spell Cash Flow and What Does?
Mastering Tough Conversations: Turn Conflict into Clarity, …
Enhancing Pivot Tables with Images: Visualize Your Data Lik…
Discover how Emotional Intelligence turns AI from a technic…
Understanding Financial Statements for Non-Financial Profes…
SOPs - How to Write Them to Satisfy those Inspectors
Managing Projects When AI Joins the Team: Human Judgment, A…